Stock listing

NASDAQ:SCLN SciClone Pharmaceuticals Inc Stock

Follow SciClone Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SCLN

$11.15 USD

Close on Oct 13, 2017 · No longer trades

Dec 31, 1997 to last close +224.3% · monthly closes, Dec 31, 1997 – Oct 13, 2017
Lowest – highest close
$0.68 – $20.63 USDSince Dec 31, 1997 · lowest Dec 30, 2008 · highest Mar 7, 2000

Delisted NASDAQ:SCLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SCLN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

SciClone Pharmaceuticals Inc on 6ix

Decks
3 decks · latest Jan 7, 2013

Where SciClone Pharmaceuticals Inc is listed

ListingExchangeCountryCurrency
NASDAQ:SCLN · This page · DelistedNASDAQUnited StatesUSD
HKEX:6600 臥安機器人 · DelistedHKEXHong KongHKD

Decks

DeckKindSlidesDate
Investor Presentation (January 2013)Investor deck22 slidesJan 7, 2013
Investor Presentation (January 2010)Investor deck22 slidesJan 11, 2010
Proxy Contest (February 2009)Proxy contest35 slidesFeb 9, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Peter Barrett
Other companies: Obsidian Therapeutics, Inc. (Board Member · Since at least Aug 3, 2026); Synlogic Inc (Chairman, Partner, Atlas Venture · Since at least Aug 28, 2017); Revvity, Inc. (Partner, Atlas Venture · Since at least Feb 6, 2012); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Sep 29, 2014 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – May 10, 2022 · Past); Momenta Pharmaceuticals Inc (Director · Jun 15, 2006 – Jun 5, 2008 · Past); Alnylam Pharmaceuticals, Inc. (Director · Feb 23, 2006 – Jun 1, 2006 · Past)
Director · Apr 18, 2011 – Jun 7, 2012 · Past
Nancy Chang
Other companies: Immix Biopharma, Inc. (Independent Director · Since at least Sep 8, 2025); Galera Therapeutics, Inc. (Director · Since at least Dec 30, 2024); W&T Offshore, Inc. (Director · Since at least Apr 28, 2023); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Charles River Laboratories International, Inc. (Director · Oct 24, 2007 – May 7, 2010 · Past); Tanox Inc (Director · Dec 31, 2005 – Nov 2, 2006 · Past)
Director · Sep 17, 2013 – Oct 13, 2017 · Past
Anthony Gregg Lapointe
Other companies: Astria Therapeutics Inc (Director · Since at least Jan 3, 2019); Rigel Pharmaceuticals, Inc. (Director · Since at least Oct 31, 2017); Soligenix, Inc. (Director · Since at least Mar 10, 2009); Raptor Pharmaceutical Corp (Director · Jan 1, 2015 – Oct 24, 2016 · Past); Questcor Pharmaceuticals Inc (Director · Oct 9, 2009 – Jan 1, 2010 · Past)
Director · Mar 30, 2009 – Oct 13, 2017 · Past
Jon S. Saxe
Other companies: Vistagen Therapeutics, Inc. (Chair of the Board · Since at least May 11, 2011); Durect Corporation (Director · Jun 20, 2006 – Jun 17, 2020 · Past); Sciele Pharma Inc (Director · Jun 15, 2006 – May 23, 2008 · Past); PDL BioPharma Inc (Director · Jan 4, 2006 – Apr 9, 2008 · Past); Questcor Pharmaceuticals Inc (Director · Jan 1, 2006 – Jan 1, 2006 · Past)
Director · Jun 13, 2006 – Oct 13, 2017 · Past
Richard J. Hawkins
Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); Lumos Pharma Inc (Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past)
Director · Oct 13, 2017 – Oct 13, 2017 · Past
Gary Titus
Other companies: Kosan Biosciences Inc (Sr. VP and CFO · Sep 5, 2006 – Jun 26, 2008 · Past); Oruka Therapeutics, Inc. (Chief Acct.Officer · Aug 1, 2006 – Aug 30, 2006 · Past)
Senior VP Finance & CFO · Dec 8, 2008 – May 31, 2012 · Past
Stephanie Wong
Other companies: AN2 Therapeutics, Inc. (Director · Since at least Mar 24, 2022); Calithera Biosciences, Inc. (See Remarks · Jan 1, 2017 – Jan 23, 2023 · Past)
VP, Finance and Controller · Aug 3, 2012 – Apr 4, 2013 · Past
Dean S Woodman
Other companies: MarineMax, Inc. (fl) (Director · Dec 30, 2005 – Aug 7, 2019 · Past)
Director · Jun 13, 2006 – May 23, 2011 · Past
Raymond Anthony Low
Other companies: AXT Inc (Chief Financial Officer · Feb 26, 2007 – Nov 5, 2012 · Past)
VP, Finance & Controller, Director · Oct 15, 2013 – Oct 13, 2017 · Past
Wilson Wai-Shun Cheung
Other companies: AXT Inc (Chief Financial Officer · Oct 27, 2006 – Nov 10, 2008 · Past)
CFO & Senior VP, Finance · Jul 16, 2013 – Oct 13, 2017 · Past
All 20 people
PersonSeat
Carey ChernGeneral Counsel · Nov 14, 2016 – Oct 13, 2017 · Past
Friedhelm BlobelPresident, CEO, Director, Director · Jun 2, 2006 – Oct 13, 2017 · Past
Hans P SchmidPres & Mng Dir, SciClone Int'l · Feb 23, 2006 – May 14, 2010 · Past
Israel RiosSr. VP, Medical Affairs & CMO · Mar 13, 2012 – Mar 15, 2012 · Past
John D BaxterDirector · Jun 13, 2006 – May 21, 2009 · Past
Lan XieVP Finance, China CFO · Aug 3, 2012 – Oct 13, 2017 · Past
Min YinVP Compliance & Internal Audit · Jun 7, 2012 – Mar 14, 2014 · Past
Roberto CameriniDirector · Mar 30, 2009 – Jun 14, 2011 · Past
Simon LiDirector · Jan 10, 2013 – Oct 13, 2017 · Past
Trevor M JonesDirector · Mar 30, 2009 – Jun 30, 2011 · Past

Open People

Log in to ask 6ix AI your own questions about SciClone Pharmaceuticals Inc.